Skye Bioscience's total assets for Q2 2025 were $52.16M, a decrease of -19.50% from the previous quarter. SKYE total liabilities were $8.48M for the fiscal quarter, a 53.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.